Reviewing Chemours Company (The) (CC) & Its Competitors

Chemours Company (The) (NYSE: CC) is one of 35 publicly-traded companies in the “Commodity Chemicals” industry, but how does it weigh in compared to its competitors? We will compare Chemours Company (The) to related companies based on the strength of its risk, institutional ownership, dividends, valuation, profitability, analyst recommendations and earnings.

Analyst Ratings

This is a summary of recent ratings for Chemours Company (The) and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours Company (The) 0 0 6 0 3.00
Chemours Company (The) Competitors 104 789 1174 34 2.54

Chemours Company (The) currently has a consensus target price of $51.83, indicating a potential downside of 9.05%. As a group, “Commodity Chemicals” companies have a potential downside of 0.81%. Given Chemours Company (The)’s competitors higher probable upside, analysts plainly believe Chemours Company (The) has less favorable growth aspects than its competitors.

Volatility & Risk

Chemours Company (The) has a beta of 3.6, meaning that its stock price is 260% more volatile than the S&P 500. Comparatively, Chemours Company (The)’s competitors have a beta of 1.17, meaning that their average stock price is 17% more volatile than the S&P 500.


This table compares Chemours Company (The) and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemours Company (The) 4.96% 122.97% 6.77%
Chemours Company (The) Competitors -23.29% 24.50% 5.88%


Chemours Company (The) pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Chemours Company (The) pays out 8.1% of its earnings in the form of a dividend. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 48.3% of their earnings in the form of a dividend.

Earnings & Valuation

This table compares Chemours Company (The) and its competitors gross revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Chemours Company (The) $5.74 billion $1.07 billion 38.51
Chemours Company (The) Competitors $4.16 billion $893.20 million 35.97

Chemours Company (The) has higher revenue and earnings than its competitors. Chemours Company (The) is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

73.0% of Chemours Company (The) shares are owned by institutional investors. Comparatively, 69.2% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 1.1% of Chemours Company (The) shares are owned by insiders. Comparatively, 8.3% of shares of all “Commodity Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.


Chemours Company (The) beats its competitors on 10 of the 15 factors compared.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

What are top analysts saying about Chemours Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Chemours Company (The) and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit